Search Results
Sep 18, 2025, 08:30 ET interop.io Launches io.Intelligence to Accelerate Secure Enterprise Deployment of AI Copilots
cases, with a focus on delivering business outcomes. Andy Menzies joins as Commercial Director, bringing decades of AI and ML experience to guide go-to-market strategy and partnerships. "io.Intelligence improves the outcome of AI copilot adoption for today's business
More news about: interop.io
Sep 18, 2025, 08:30 ET interop.io Launches io.Intelligence to Accelerate Secure Enterprise Deployment of AI Copilots
cases, with a focus on delivering business outcomes. Andy Menzies joins as Commercial Director, bringing decades of AI and ML experience to guide go-to-market strategy and partnerships. "io.Intelligence improves the outcome of AI copilot adoption for today's business
More news about: interop.io
Sep 18, 2025, 08:01 ET Lush Cosmetics Is Sweetening Up Fall With 'Café Gourmand' - The Pop-Up Cafe Will Open In NYC's West Village on Friday, September 19
Pumpkin Spice Latte Shower Gel$12.50 USD - 100mL$26.00 USD - 250mL$40.00 USD - 500mL A Lush shower gel that smells like a pumpkin spiced latte? You're not dreaming! This
More news about: Lush Cosmetics
Sep 18, 2025, 08:00 ET Penguin Ai Strengthens Executive Leadership Team With New Chief Strategy Officer, Additional Key Hires and Advisors
Ayyadevara, Chief AI Officer, formerly of UnitedHealth Group, Amazon and American Express, with 20 AI patents filed and six published books on AI, ML, computer vision;
More news about: Penguin Ai
Sep 18, 2025, 01:04 ET Biovance Capital leads Series A Financing in Mondego Bio together with OrbiMed and Torrey Pines
company," added Iain Dukes, PhD, Venture Partner at OrbiMed. The lead programs are based on research initially developed by Eilean Therapeutics, an AI/ML supported oncology platform co-founded by OrbiMed and Torrey Pines. About Biovance Capital Biovance
More news about: Mondego Bio
Sep 18, 2025, 00:30 ET IIM Udaipur Partners with MoSPI, NITI Aayog, and Bhashini to Strengthen India's Data, Monitoring, and AI Ecosystem
under Anusandhan Mitra in collaboration with Bhashini, the National Language Translation Mission. The initiative aims to advance AI and ML for Indian languages by creating regional hubs, strengthening datasets for under-represented languages, fostering research in speech and language technologies,
More news about: Indian Institute of Management Udaipur (IIMU)
Sep 17, 2025, 18:01 ET Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, reduced A1C by an average of 2.2% in a Phase 3 trial of children and adolescents with type 2 diabetes
more Mounjaro is a prescription medicine available as a pre-filled single-dose pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection. For more information, call 1-800-LillyRX (800-545-5979) [or go to
More news about: Eli Lilly and Company
Sep 17, 2025, 12:58 ET Minelab Premieres the VANQUISH 60 Series: Simple Yet Powerful
coil VANQUISH 460: V10X coil and wired headphones VANQUISH 560: V12X and wired headphones VANQUISH 560 Pro-Pack: V12X and V8X coils and ML60 low-latency Bluetooth® LE audio wireless earbudsAvailability The VANQUISH 60 Series will be available soon through Minelab's
More news about: Minelab Electronics PTY LTD
Sep 17, 2025, 12:20 ET Gurucul Unveils Industry's First AI-Powered Insider Risk Management Platform with Native Convergence and Agentic AI for Autonomous Threat Detection and Response
coverage across human users, non-human identities, AI agents, and state-sponsored threats with hundreds of out-of-the-box use cases and thousands of ML-driven detections.AI Analyst & Sme AI Copilot: AI-powered alert triage and response trained on insider threat investigations empower
More news about: Gurucul
Sep 17, 2025, 11:41 ET Cohesity revela inovações de segurança e parcerias para ajudar organizações a fortalecer pilares da resiliência cibernética
por IA, a Cohesity ajuda as organizações a fortalecer a resiliência, acelerar a recuperação e reduzir os custos de TI. Com segurança Zero Trust e IA/ML avançados, a plataforma Cohesity Data Cloud tem a confiança de clientes em mais de 140 países, incluindo 70% das empresas da Global 500. A Cohesity também
More news about: Cohesity
Sep 17, 2025, 11:40 ET Cohesity e Semperis anunciam oferta inovadora que unifica a resiliência de dados e de identidade
por IA, a Cohesity ajuda as organizações a fortalecer a resiliência, acelerar a recuperação e reduzir os custos de TI. Com segurança Zero Trust e IA/ML avançados, a plataforma Cohesity Data Cloud tem a confiança de clientes em mais de 140 países, incluindo 70% das empresas da Global 500. A Cohesity também
More news about: Cohesity
Sep 17, 2025, 10:50 ET E-Cigarette Market Is Projected to Reach US$ 52.13 Billion By 2031 With A CAGR Of 10.8% |The Insight Partners
its latest devices, the iSilk and iSilk Lite, combining sleek design with reliable performance. The iSilk features an 850mAh rechargeable battery, a 2ml refillable pod, and an eye-shaped display for real-time battery level monitoring. Its mesh coil technology delivers smooth, full-flavor vaping. The iSilk
More news about: The Insight Partners
Sep 17, 2025, 10:15 ET Global System-on-Chip Design Service Market Set to Reach $5.5 Billion by 2031, Driven by Automotive and Consumer Electronics Demand | Valuates Reports
prototyping, and product engineering solutions.Ignitarium – Offers semiconductor design, verification, and SoC development services for AI/ML, automotive, and consumer devices.Faraday Tech – Provides ASIC and SoC design services with turnkey solutions covering
More news about: Valuates Reports
Sep 17, 2025, 08:36 ET Elaris Launches: AI That Already Knows Your Audience
https://drive.google.com/drive/folders/1bK3ml4oKxpHJYDWQg648uaRkzhoD4uMt Media contact: Sebastian Weyer+4915753072551
More news about: Elaris
Sep 17, 2025, 08:30 ET MapLight Therapeutics Announces Initiation of Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
[email protected] About ML-007C-MA ML-007C-MA, also referred to as ML-007C/PAC, is an oral, extended-release, fixed-dose combination of the investigational M1/M4 muscarinic agonist, ML-007, co-formulated with a peripherally acting anticholinergic (PAC). ML-007C-MA is designed
More news about: MapLight Therapeutics, Inc.
Sep 17, 2025, 07:57 ET RevitaLash® Cosmetics Announces 13th Consecutive Win of Prestigious Allure Best of Beauty Award for RevitaBrow® Advanced
over-grooming, and styling products, leading to healthier-looking, more luxurious brows. RevitaBrow® Advanced Eyebrow Conditioner (3.0 mL) retails for $111.00 USD and is available at select physicians' offices, salons, spas, and specialty retailers and online
More news about: RevitaLash Cosmetics
Sep 17, 2025, 07:53 ET Asprey Studio announces its partnership with Vinous, one of the world's most influential wine publications
Italy and Champagne. Wine collectors will have the opportunity to acquire this exceptional limited-edition bottling, from 750ml bottles to Double Magnums, the first in a series of rare, collectible releases from the Asprey Studio x Vinous collaboration. The wines are made
More news about: Vinous Media LLC
Sep 17, 2025, 07:32 ET Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars
the U.S. Food and Drug Administration (FDA) has approved Bosaya™ (denosumab-kyqq) 60 mg/mL injection for subcutaneous use in a single dose prefilled syringe (PFS), and Aukelso™ (denosumab-kyqq) 120 mg/1.7 mL (70 mg/mL) injection for subcutaneous use in a single-dose vial, biosimilars of Prolia® and Xgeva®
More news about: Biocon Biologics